Revolax SubQ With Lidocaine (1 x 1.1ml)

Revolax

Dermal Filler

Hyaluronic Acid Dermal Filler for Deep Tissue Augmentation and Facial Contouring

CE Marked Class III medical device (dermal filler with lidocaine) for use in the EU/UK and other CE Recognising markets
Manufactured in facilities operating under ISO 13485 Compliant quality management systems for medical devices
Non Animal Derived, biodegradable hyaluronic acid meeting high purity and low endotoxin specifications

CE Marked Class III medical device (dermal filler with lidocaine) for use in the EU/UK and other CE Recognising markets
Manufactured in facilities operating under ISO 13485 Compliant quality management systems for medical devices
Non Animal Derived, biodegradable hyaluronic acid meeting high purity and low endotoxin specifications
Produced in accordance with applicable EU/UK medical device regulations and national requirements for injectable dermal fillers
Intended exclusively for professional use by qualified medical practitioners, in line with local regulatory and professional guidelines

Description

Revolax SubQ With Lidocaine (1 x 1.1ml) is a premium, highly cross-linked, monophasic hyaluronic acid dermal filler engineered for deep subcutaneous tissue augmentation and robust facial contouring. With a high HA concentration of 24 mg/ml and 0.3% lidocaine, it is the thickest and most viscoelastic product in the Revolax range, delivering powerful lifting capacity, structural support, and long-lasting volume to areas such as the cheeks, jawline, chin, nose, and deep nasolabial folds. The smooth yet dense monophasic gel integrates evenly into dermal and subdermal tissues, allowing practitioners to sculpt and define facial features while maintaining a natural, harmonious appearance and minimising product migration. Lidocaine provides local anaesthesia for a more comfortable treatment experience and smoother injection control. Manufactured to stringent quality standards with highly purified, non-animal-derived hyaluronic acid and low endotoxin levels, Revolax SubQ is CE-marked as a Class III medical device and is designed for use by trained medical professionals for non-surgical facial rejuvenation and contouring.

Bnefits

Thickest and most robust filler in the Revolax range, optimised for deep volume restoration and structural support
High lifting capacity suitable for contouring and reshaping cheeks, chin, jawline, nose, and other areas requiring strong projection
Monophasic, cross-linked gel with high viscoelasticity for stable volume, shape retention, and reduced risk of migration
Contains 24 mg/ml non-animal hyaluronic acid and 0.3% lidocaine for effective volumisation with enhanced patient comfort
Designed for treatment of deep to extremely severe wrinkles, including pronounced nasolabial folds and deep facial folds
Results typically last approximately 12–18 months, depending on treatment area, technique, and individual metabolism
Highly purified HA with low endotoxin levels to reduce the likelihood of adverse reactions and improve tolerability
Biodegradable and non-permanent filler that is fully resorbed over time and can be dissolved with hyaluronidase if required
CE-marked Class III medical device manufactured under strict quality and safety standards
Smooth, consistent extrusion force for precise placement, even distribution, and predictable aesthetic outcomes

Indications

Multiple distributors

Revolax Deep

Aesthetic Injectables

EUR 477.75
£20.00
10 more

Multiple distributors

Revolax Fine

Aesthetic Injectables

EUR 477.75
£20.00
11 more

Multiple distributors